SGLT2 inhibitors and Mortality in Diabetic Cancer Patients. Cardioprotective and Anticancer effects

Authors

Kalliopi Keramida, Department of Cardiology, General Anticancer Oncological Hospital, Agios Savvas, Athens, Greece.
Ali Ahmed, Department of Medicine, Veterans Affairs Medical Center, Washington, DC, Department of Medicine, Georgetown University, Washington, DC, Department of Medicine, George Washington University, Washington, DC.
Gerasimos Filippatos, Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Document Type

Journal Article

Publication Date

6-6-2025

Journal

European heart journal. Cardiovascular pharmacotherapy

DOI

10.1093/ehjcvp/pvaf044

APA Citation

Keramida, Kalliopi; Ahmed, Ali; and Filippatos, Gerasimos, "SGLT2 inhibitors and Mortality in Diabetic Cancer Patients. Cardioprotective and Anticancer effects" (2025). GW Authored Works. Paper 7450.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/7450

Department

Medicine